JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) Short Interest Down 6.0% in March

JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) saw a large decrease in short interest during the month of March. As of March 31st, there was short interest totalling 590,800 shares, a decrease of 6.0% from the March 15th total of 628,800 shares. Based on an average trading volume of 0 shares, the short-interest ratio is presently ? days.

JCR Pharmaceuticals Stock Performance

Shares of JCRRF opened at $5.22 on Thursday. JCR Pharmaceuticals has a 52 week low of $5.22 and a 52 week high of $6.20. The stock has a fifty day moving average of $6.41 and a 200-day moving average of $8.14.

About JCR Pharmaceuticals

JCR Pharmaceuticals Co, Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V.